These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25865226)

  • 21. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
    Aghi M; Rabkin S; Martuza RL
    Clin Neurosurg; 2006; 53():65-76. PubMed ID: 17380741
    [No Abstract]   [Full Text] [Related]  

  • 23. Glioma therapy in adults.
    Norden AD; Wen PY
    Neurologist; 2006 Nov; 12(6):279-92. PubMed ID: 17122724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
    Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
    Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
    Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
    Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
    Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
    J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
    Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
    Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
    Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
    Wang L; Tu Q; Zhou W; Zhou R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series.
    Rusthoven KE; Olsen C; Franklin W; Kleinschmidt-DeMasters BK; Kavanagh BD; Gaspar LE; Lillehei K; Waziri A; Damek DM; Chen C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):211-7. PubMed ID: 20732762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas.
    Yin T; Wang P; Li J; Zheng R; Zheng B; Cheng D; Li R; Lai J; Shuai X
    Biomaterials; 2013 Jun; 34(18):4532-43. PubMed ID: 23522375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.
    Branle F; Lefranc F; Camby I; Jeuken J; Geurts-Moespot A; Sprenger S; Sweep F; Kiss R; Salmon I
    Cancer; 2002 Aug; 95(3):641-55. PubMed ID: 12209758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing of the TPM1 gene induces radioresistance of glioma U251 cells.
    Du HQ; Wang Y; Jiang Y; Wang CH; Zhou T; Liu HY; Xiao H
    Oncol Rep; 2015 Jun; 33(6):2807-14. PubMed ID: 25873252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive functioning in patients of high-grade gliomas.
    Ladislav S
    J Cancer Res Ther; 2013; 9(4):757-8. PubMed ID: 24518741
    [No Abstract]   [Full Text] [Related]  

  • 39. Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy.
    Zong Z; Hua L; Wang Z; Xu H; Ye C; Pan B; Zhao Z; Zhang L; Lu J; Mei LH; Rutong Y
    Drug Deliv; 2019 Dec; 26(1):34-44. PubMed ID: 30744436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farewell to monomodality treatment in patients with WHO lower grade glioma?
    Le Rhun E; Gorlia T
    Eur J Cancer; 2018 Jan; 88():109-114. PubMed ID: 29239741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.